Tower Research Capital (TRC)’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20K Buy
254
+235
+1,237% +$18.9K ﹤0.01% 3485
2025
Q4
$1.38K Buy
+19
New +$1.35K ﹤0.01% 4703
2025
Q3
Sell
-18
Closed -$1.14K 5314
2025
Q2
$1.14K Buy
+18
New +$1.05K ﹤0.01% 4868
2023
Q4
Sell
-2,710
Closed -$135K 5980
2023
Q3
$135K Buy
+2,710
New +$141K ﹤0.01% 1742
2023
Q2
Sell
-2,900
Closed -$143K 6119
2023
Q1
$143K Buy
2,900
+2,800
+2,800% +$138K ﹤0.01% 1565
2022
Q4
$5K Hold
100
﹤0.01% 4852
2022
Q3
$4K Sell
100
-27
-21% -$1.31K ﹤0.01% 5244
2022
Q2
$6K Buy
+127
New +$6.76K ﹤0.01% 4919

Other funds holding EMXC

Tower Research Capital (TRC)'s EMXC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 1,237% in Q1 2026, buying an estimated $18.9K and bringing the position to 254 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

Tower Research Capital (TRC) first reported a position in EMXC in Q2 2022 and has held it in 8 quarters since. The position peaked at $143K in Q1 2023. 926 funds tracked by Wall St. Rank hold EMXC as of Q1 2026.

  • Tower Research Capital (TRC) held 254 shares of iShares MSCI Emerging Markets ex China ETF worth $20K as of Q1 2026.
  • Tower Research Capital (TRC) bought 235 iShares MSCI Emerging Markets ex China ETF shares in Q1 2026, an estimated $18.9K.
  • iShares MSCI Emerging Markets ex China ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3485 holding.
  • Tower Research Capital (TRC) first reported a position in iShares MSCI Emerging Markets ex China ETF in Q2 2022 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s iShares MSCI Emerging Markets ex China ETF position peaked at $143K in Q1 2023.
  • 926 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.